These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
266 related items for PubMed ID: 28465529
1. Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells. Hasan MK, Yu J, Chen L, Cui B, Widhopf Ii GF, Rassenti L, Shen Z, Briggs SP, Kipps TJ. Leukemia; 2017 Dec; 31(12):2615-2622. PubMed ID: 28465529 [Abstract] [Full Text] [Related]
9. Cirmtuzumab inhibits Wnt5a-induced Rac1 activation in chronic lymphocytic leukemia treated with ibrutinib. Yu J, Chen L, Cui B, Wu C, Choi MY, Chen Y, Zhang L, Rassenti LZ, Widhopf Ii GF, Kipps TJ. Leukemia; 2017 Jun; 31(6):1333-1339. PubMed ID: 27904138 [Abstract] [Full Text] [Related]
10. Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia. Janovska P, Poppova L, Plevova K, Plesingerova H, Behal M, Kaucka M, Ovesna P, Hlozkova M, Borsky M, Stehlikova O, Brychtova Y, Doubek M, Machalova M, Baskar S, Kozubik A, Pospisilova S, Pavlova S, Bryja V. Clin Cancer Res; 2016 Jan 15; 22(2):459-69. PubMed ID: 26240275 [Abstract] [Full Text] [Related]
11. Wnt5a induces ROR1 to recruit cortactin to promote breast-cancer migration and metastasis. Hasan MK, Widhopf GF, Zhang S, Lam SM, Shen Z, Briggs SP, Parker BA, Kipps TJ. NPJ Breast Cancer; 2019 Jan 15; 5():35. PubMed ID: 31667337 [Abstract] [Full Text] [Related]
19. Destabilization of ROR1 enhances activity of Ibrutinib against chronic lymphocytic leukemia in vivo. Liu Z, Liu J, Zhang T, Shi M, Chen X, Chen Y, Yu J. Pharmacol Res; 2020 Jan 03; 151():104512. PubMed ID: 31726100 [Abstract] [Full Text] [Related]